Further studies analyzing the molecular and cellular mechanisms underlying the effects of PRTN3 on tumor angiogenesis using CRC cell lines and neutrophils and the relationship between PRTN3 and stromal neutrophils, are needed to confirm our results. This evidence concerns the gene PRTN3 and colorectal carcinoma.